Influenza Diagnostics Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2018-2026
REPORT DESCRIPTION Influenza Diagnostics Market – Overview According to the Centers for Disease Control and Prevention (CDC), in U.S. Influenza resulted in 49,000,000 symptomatic illnesses and 79,000 deaths in 2017-2018. High risk of influenza infection is observed in pregnant women, pediatrics, geriatrics, patients with low immunity that suffer from chronic illness, and healthcare professionals. High prevalence of influenza and increasing research funding for influenza diagnostics are major factors that are expected to drive the market growth over the forecast period. According to the World Health Organization (WHO), influenza is expected to result in around 3 to 5 million cases of severe illness and around 290,000 to 650,000 deaths in 2018 worldwide. In 2014, National Institute of Allergy and Infectious Disease (NIAID) collaborated with The National Institutes of Health (NIH) Autoimmune Disease Coordinating Committee (ADCC) and supports The Center of Excellence in Influenza Research and Surveillance (CIERS) to advance the understanding of influenza virus. High geriatric population prone to influenza, increasing awareness about the disease along with high demand for advanced and more efficient influenza diagnostic tests are expected to drive growth of the influenza diagnostics market.
REPORT DESCRIPTION Influenza Diagnostics Market Taxonomy: Traditional Diagnostic Tests Rapid Influenza Diagnostic Tests (RIDT) Viral Culture Direct Fluorescent Antibody (DFA) Tests Serological Assays Molecular Diagnostic Assays RT-PCR Nucleic Acid Sequence-Based Amplification (NASBA) Tests Loop-Mediated Isothermal Amplification-Based Assays (LAMP) Simple Amplification-Based Assays (SAMBA) Get Request a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/2414
REPORT DESCRIPTION Influenza Diagnostics Market – Key Players
Roche Diagnostics Becton Dickinson and Company Thermo Fisher Scientific Alere Quidel Corporation
Key players in the market are focused on research and development activities in order to offer diagnostic devices that are cost-effective and efficient. For instance, in 2016, Roche received the U.S. FDA clearance and Clinical Laboratory Improvement Amendments (CLIA) waiver for its cobas Influenza A/B & RSV test. The test is used with the cobas Liat system and assists in molecular testing of flu A/B and RSV. Get More Inf @ https://www.coherentmarketinsights.com/ongoing-insight/influenza-diagnostics-market-2414
ABOUT COHERENT MARKET INSIGHTS
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES INDUSTRY ANALYSIS MARKET INTELLIGENCE SERVICES
CUSTOMIZED RESEARCH CONSULT STUDIES
SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES
ABOUT CMI SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
Global Leading Equipment and System Manufacturers Component Providers and System Integrators Distributors, Retailors and Value Added Resellers Healthcare IT Solutions Developers Marketing Consultancies and the Advertising Industry Private and Government organization Outsourcing Companies
ABOUT US KEY STATS
RESEARCH SOLUTIONS
FEASIBILITY STUDIES
GLOBAL REPORTS
100+ Insights Published Per Year
150+
Consulting Projects Till Date
125+
Clients Worldwide Per Year
110+
COUNTRY ANALYSIS
CONSULT PROJECTS SURVEY RESEARCH
EXCEL FORECAST DATABASE
COMPETITIVE ASSESSMENT
TECHNOLOGY SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique —we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.
THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702